The survey for anti-emetic guideline by using questioner

Toshiaki Saeki, Kazuo Tamura, Keisuke Aiba, Kenjiro Aogi, Keiko Lino, Chiyo Imamura, Kenji Eguchi, Kenji Okita, Yoshikazu Kagami, Ryuhei Tanaka, Kazuhiko Nakagawa, Hirofumi Fujii, Narikazu Boku, Kazuo Matsuura, Makoto Wada, Tatsuo Akechi, Yuichi Kakudo, Yong Il Kim, Hide Nori Sasaki, Yasuo Shima & 9 others Masayuki Takeda, Eijiro Nagasaki, Toshihiko Nishidate, Mitsue Saito, Yukino Ashikaga, Yusuke Tanigawara, Koichi Hirata, Chikashi Ishioka, Masahiko Nishiyama

Research output: Contribution to journalArticle

Abstract

Background: Japan Society of Clinical Oncology published a guideline for anti-emetic therapy two years ago. This guideline was a first evidence based guideline of anti-emetic treatment for the patients who received chemotherapy in Japan. To investigate a current situation of anti-emetic treatment in Japan, we analyzed the data from nationwide questionnaire. Material: Questionnaire analysis; From June 2012 to August 2012, we gave 24 questionnaires on the Japan Society of Clinical Oncology Website and collected the response from the member of 5 major academic oncology societies. The questionnaires included degree of recognition, penetration, usefulness, problems and user type of medial stuff for the anti-emetic guideline published by (JSCO). Results: Questionnaire; 1,529 medical stuff responded to our questionnaire. 1,308 (85.5%) stuffs recognized JSCO guidelines, 586 (51%) had regard for guideline and 489 (42.6%) referred to the guideline. 899 (78.3%) changed their practice in clinic to recommended practice by the guideline. But 385 (33.5%) complained high medical cost of recommended anti-emetic therapy. Conclusions: Degree of recognition and penetration of our guideline for anti-emetic therapy were very high in Japan.

Original languageEnglish
Pages (from-to)305-311
Number of pages7
JournalJapanese Journal of Cancer and Chemotherapy
Volume42
Issue number3
Publication statusPublished - 2015 Mar 1

Fingerprint

Antiemetics
Guidelines
Japan
Medical Oncology
Therapeutics
Surveys and Questionnaires
Practice Guidelines
Costs and Cost Analysis
Drug Therapy

Keywords

  • Anti-emetic guideline
  • Questionnaire

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Saeki, T., Tamura, K., Aiba, K., Aogi, K., Lino, K., Imamura, C., ... Nishiyama, M. (2015). The survey for anti-emetic guideline by using questioner. Japanese Journal of Cancer and Chemotherapy, 42(3), 305-311.

The survey for anti-emetic guideline by using questioner. / Saeki, Toshiaki; Tamura, Kazuo; Aiba, Keisuke; Aogi, Kenjiro; Lino, Keiko; Imamura, Chiyo; Eguchi, Kenji; Okita, Kenji; Kagami, Yoshikazu; Tanaka, Ryuhei; Nakagawa, Kazuhiko; Fujii, Hirofumi; Boku, Narikazu; Matsuura, Kazuo; Wada, Makoto; Akechi, Tatsuo; Kakudo, Yuichi; Kim, Yong Il; Sasaki, Hide Nori; Shima, Yasuo; Takeda, Masayuki; Nagasaki, Eijiro; Nishidate, Toshihiko; Saito, Mitsue; Ashikaga, Yukino; Tanigawara, Yusuke; Hirata, Koichi; Ishioka, Chikashi; Nishiyama, Masahiko.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 42, No. 3, 01.03.2015, p. 305-311.

Research output: Contribution to journalArticle

Saeki, T, Tamura, K, Aiba, K, Aogi, K, Lino, K, Imamura, C, Eguchi, K, Okita, K, Kagami, Y, Tanaka, R, Nakagawa, K, Fujii, H, Boku, N, Matsuura, K, Wada, M, Akechi, T, Kakudo, Y, Kim, YI, Sasaki, HN, Shima, Y, Takeda, M, Nagasaki, E, Nishidate, T, Saito, M, Ashikaga, Y, Tanigawara, Y, Hirata, K, Ishioka, C & Nishiyama, M 2015, 'The survey for anti-emetic guideline by using questioner', Japanese Journal of Cancer and Chemotherapy, vol. 42, no. 3, pp. 305-311.
Saeki T, Tamura K, Aiba K, Aogi K, Lino K, Imamura C et al. The survey for anti-emetic guideline by using questioner. Japanese Journal of Cancer and Chemotherapy. 2015 Mar 1;42(3):305-311.
Saeki, Toshiaki ; Tamura, Kazuo ; Aiba, Keisuke ; Aogi, Kenjiro ; Lino, Keiko ; Imamura, Chiyo ; Eguchi, Kenji ; Okita, Kenji ; Kagami, Yoshikazu ; Tanaka, Ryuhei ; Nakagawa, Kazuhiko ; Fujii, Hirofumi ; Boku, Narikazu ; Matsuura, Kazuo ; Wada, Makoto ; Akechi, Tatsuo ; Kakudo, Yuichi ; Kim, Yong Il ; Sasaki, Hide Nori ; Shima, Yasuo ; Takeda, Masayuki ; Nagasaki, Eijiro ; Nishidate, Toshihiko ; Saito, Mitsue ; Ashikaga, Yukino ; Tanigawara, Yusuke ; Hirata, Koichi ; Ishioka, Chikashi ; Nishiyama, Masahiko. / The survey for anti-emetic guideline by using questioner. In: Japanese Journal of Cancer and Chemotherapy. 2015 ; Vol. 42, No. 3. pp. 305-311.
@article{87da27e370e349d39fa2777f34957f04,
title = "The survey for anti-emetic guideline by using questioner",
abstract = "Background: Japan Society of Clinical Oncology published a guideline for anti-emetic therapy two years ago. This guideline was a first evidence based guideline of anti-emetic treatment for the patients who received chemotherapy in Japan. To investigate a current situation of anti-emetic treatment in Japan, we analyzed the data from nationwide questionnaire. Material: Questionnaire analysis; From June 2012 to August 2012, we gave 24 questionnaires on the Japan Society of Clinical Oncology Website and collected the response from the member of 5 major academic oncology societies. The questionnaires included degree of recognition, penetration, usefulness, problems and user type of medial stuff for the anti-emetic guideline published by (JSCO). Results: Questionnaire; 1,529 medical stuff responded to our questionnaire. 1,308 (85.5{\%}) stuffs recognized JSCO guidelines, 586 (51{\%}) had regard for guideline and 489 (42.6{\%}) referred to the guideline. 899 (78.3{\%}) changed their practice in clinic to recommended practice by the guideline. But 385 (33.5{\%}) complained high medical cost of recommended anti-emetic therapy. Conclusions: Degree of recognition and penetration of our guideline for anti-emetic therapy were very high in Japan.",
keywords = "Anti-emetic guideline, Questionnaire",
author = "Toshiaki Saeki and Kazuo Tamura and Keisuke Aiba and Kenjiro Aogi and Keiko Lino and Chiyo Imamura and Kenji Eguchi and Kenji Okita and Yoshikazu Kagami and Ryuhei Tanaka and Kazuhiko Nakagawa and Hirofumi Fujii and Narikazu Boku and Kazuo Matsuura and Makoto Wada and Tatsuo Akechi and Yuichi Kakudo and Kim, {Yong Il} and Sasaki, {Hide Nori} and Yasuo Shima and Masayuki Takeda and Eijiro Nagasaki and Toshihiko Nishidate and Mitsue Saito and Yukino Ashikaga and Yusuke Tanigawara and Koichi Hirata and Chikashi Ishioka and Masahiko Nishiyama",
year = "2015",
month = "3",
day = "1",
language = "English",
volume = "42",
pages = "305--311",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "3",

}

TY - JOUR

T1 - The survey for anti-emetic guideline by using questioner

AU - Saeki, Toshiaki

AU - Tamura, Kazuo

AU - Aiba, Keisuke

AU - Aogi, Kenjiro

AU - Lino, Keiko

AU - Imamura, Chiyo

AU - Eguchi, Kenji

AU - Okita, Kenji

AU - Kagami, Yoshikazu

AU - Tanaka, Ryuhei

AU - Nakagawa, Kazuhiko

AU - Fujii, Hirofumi

AU - Boku, Narikazu

AU - Matsuura, Kazuo

AU - Wada, Makoto

AU - Akechi, Tatsuo

AU - Kakudo, Yuichi

AU - Kim, Yong Il

AU - Sasaki, Hide Nori

AU - Shima, Yasuo

AU - Takeda, Masayuki

AU - Nagasaki, Eijiro

AU - Nishidate, Toshihiko

AU - Saito, Mitsue

AU - Ashikaga, Yukino

AU - Tanigawara, Yusuke

AU - Hirata, Koichi

AU - Ishioka, Chikashi

AU - Nishiyama, Masahiko

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Background: Japan Society of Clinical Oncology published a guideline for anti-emetic therapy two years ago. This guideline was a first evidence based guideline of anti-emetic treatment for the patients who received chemotherapy in Japan. To investigate a current situation of anti-emetic treatment in Japan, we analyzed the data from nationwide questionnaire. Material: Questionnaire analysis; From June 2012 to August 2012, we gave 24 questionnaires on the Japan Society of Clinical Oncology Website and collected the response from the member of 5 major academic oncology societies. The questionnaires included degree of recognition, penetration, usefulness, problems and user type of medial stuff for the anti-emetic guideline published by (JSCO). Results: Questionnaire; 1,529 medical stuff responded to our questionnaire. 1,308 (85.5%) stuffs recognized JSCO guidelines, 586 (51%) had regard for guideline and 489 (42.6%) referred to the guideline. 899 (78.3%) changed their practice in clinic to recommended practice by the guideline. But 385 (33.5%) complained high medical cost of recommended anti-emetic therapy. Conclusions: Degree of recognition and penetration of our guideline for anti-emetic therapy were very high in Japan.

AB - Background: Japan Society of Clinical Oncology published a guideline for anti-emetic therapy two years ago. This guideline was a first evidence based guideline of anti-emetic treatment for the patients who received chemotherapy in Japan. To investigate a current situation of anti-emetic treatment in Japan, we analyzed the data from nationwide questionnaire. Material: Questionnaire analysis; From June 2012 to August 2012, we gave 24 questionnaires on the Japan Society of Clinical Oncology Website and collected the response from the member of 5 major academic oncology societies. The questionnaires included degree of recognition, penetration, usefulness, problems and user type of medial stuff for the anti-emetic guideline published by (JSCO). Results: Questionnaire; 1,529 medical stuff responded to our questionnaire. 1,308 (85.5%) stuffs recognized JSCO guidelines, 586 (51%) had regard for guideline and 489 (42.6%) referred to the guideline. 899 (78.3%) changed their practice in clinic to recommended practice by the guideline. But 385 (33.5%) complained high medical cost of recommended anti-emetic therapy. Conclusions: Degree of recognition and penetration of our guideline for anti-emetic therapy were very high in Japan.

KW - Anti-emetic guideline

KW - Questionnaire

UR - http://www.scopus.com/inward/record.url?scp=84931043037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931043037&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 305

EP - 311

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 3

ER -